| Reference |
|---|
Jia H, Moore M, Wadhwa M, Burns C. Human iPSC-Derived Endothelial Cells Exhibit Reduced Immunogenicity in Comparison With Human Primary Endothelial Cells. Stem Cells Int. 2024;2024:6153235 pubmed publisher |
Romani A, Lodi G, Casciano F, Gonelli A, Secchiero P, Zauli G, et al. Enhanced Anti-Melanoma Activity of Nutlin-3a Delivered via Ethosomes: Targeting p53-Mediated Apoptosis in HT144 Cells. Cells. 2024;13: pubmed publisher |
Koh E, Lee H, Son W, Park G, Kim J, Bae J, et al. Combinatorial immunotherapy with gemcitabine and ex vivo-expanded NK cells induces anti-tumor effects in pancreatic cancer. Sci Rep. 2023;13:7656 pubmed publisher |
Koh E, Lee H, Son W, Park G, Bae J, Park Y. Antitumor effects of NK cells expanded by activation pre‑processing of autologous feeder cells before irradiation in colorectal cancer. Oncol Lett. 2023;25:232 pubmed publisher |
Degenfeld Schonburg L, Gamperl S, Stefanzl G, Schruef A, Sadovnik I, Bauer K, et al. Antineoplastic efficacy profiles of avapritinib and nintedanib in KIT D816V+ systemic mastocytosis: a preclinical study. Am J Cancer Res. 2023;13:355-378 pubmed |
Holmgren C, Sunstr xf6 m Th xf6 rnberg E, Granqvist V, Larsson C. Induction of Breast Cancer Cell Apoptosis by TRAIL and Smac Mimetics: Involvement of RIP1 and cFLIP. Curr Issues Mol Biol. 2022;44:4803-4821 pubmed publisher |
Vecchi L, Mota S, Z xf3 ia M, Martins I, de Souza J, Santos T, et al. Interleukin-6 Signaling in Triple Negative Breast Cancer Cells Elicits the Annexin A1/Formyl Peptide Receptor 1 Axis and Affects the Tumor Microenvironment. Cells. 2022;11: pubmed publisher |
de Kay J, Carver J, Shevenell B, Kosta A, Tsibulnikov S, Certo E, et al. Decreased expression of ErbB2 on left ventricular epicardial cells in patients with diabetes mellitus. Cell Signal. 2022;96:110360 pubmed publisher |
Hurov K, Lahdenranta J, Upadhyaya P, Haines E, Cohen H, Repash E, et al. BT7480, a novel fully synthetic Bicycle tumor-targeted immune cell agonist™ (Bicycle TICA™) induces tumor localized CD137 agonism. J Immunother Cancer. 2021;9: pubmed publisher |
Shafiei Jahani P, Helou D, Hurrell B, Howard E, Quach C, Painter J, et al. CD200-CD200R immune checkpoint engagement regulates ILC2 effector function and ameliorates lung inflammation in asthma. Nat Commun. 2021;12:2526 pubmed publisher |
Mu xf1 oz Al xed a M, Nace R, Zhang L, Russell S. Serotypic evolution of measles virus is constrained by multiple co-dominant B cell epitopes on its surface glycoproteins. Cell Rep Med. 2021;2:100225 pubmed publisher |
Muñoz Alía M, Nace R, Tischer A, Zhang L, Bah E, Auton M, et al. Mev-stealth: A cd46-specific oncolytic measles virus resistant to neutralization by measles-immune human serum. PLoS Pathog. 2021;17:e1009283 pubmed publisher |
Xue J, Xu L, Zhu H, Bai M, Li X, Zhao Z, et al. CD14+CD16- monocytes are the main precursors of osteoclasts in rheumatoid arthritis via expressing Tyro3TK. Arthritis Res Ther. 2020;22:221 pubmed publisher |
Shafiei Jahani P, Hurrell B, Galle Treger L, Helou D, Howard E, Painter J, et al. DR3 stimulation of adipose resident ILC2s ameliorates type 2 diabetes mellitus. Nat Commun. 2020;11:4718 pubmed publisher |
Mota S, Vecchi L, Alves D, Cordeiro A, Guimar xe3 es G, Campos Fern xe1 ndez E, et al. Annexin A1 promotes the nuclear localization of the epidermal growth factor receptor in castration-resistant prostate cancer. Int J Biochem Cell Biol. 2020;127:105838 pubmed publisher |
Nelke J, Medler J, Weisenberger D, Beilhack A, Wajant H. CD40- and CD95-specific antibody single chain-Baff fusion proteins display BaffR-, TACI- and BCMA-restricted agonism. MAbs. 2020;12:1807721 pubmed publisher |
Kozbial A, Bhandary L, Murthy S. Effect of Monocyte Seeding Density on Dendritic Cell Generation in an Automated Perfusion-Based Culture System. Biochem Eng J. 2019;150: pubmed publisher |
Lionetti M, Cola F, Chepizhko O, Fumagalli M, Font Clos F, Ravasio R, et al. MicroRNA-222 Regulates Melanoma Plasticity. J Clin Med. 2020;9: pubmed publisher |
D Alterio C, Zannetti A, Trotta A, Ierano C, Napolitano M, Rea G, et al. New CXCR4 Antagonist Peptide R (Pep R) Improves Standard Therapy in Colorectal Cancer. Cancers (Basel). 2020;12: pubmed publisher |
Chen P, Hsieh S, Lan J, Lin C, Chang S, Chen D. Elevated Expression of C-Type Lectin Domain Family 5-Member A (CLEC5A) and Its Relation to Inflammatory Parameters and Disease Course in Adult-Onset Still's Disease. J Immunol Res. 2020;2020:9473497 pubmed publisher |
Jin J, Xue N, Liu Y, Fu R, Wang M, Ji M, et al. A novel S1P1 modulator IMMH002 ameliorates psoriasis in multiple animal models. Acta Pharm Sin B. 2020;10:276-288 pubmed publisher |
Dittmann J, Haydn T, Metzger P, Ward G, Boerries M, Vogler M, et al. Next-generation hypomethylating agent SGI-110 primes acute myeloid leukemia cells to IAP antagonist by activating extrinsic and intrinsic apoptosis pathways. Cell Death Differ. 2020;27:1878-1895 pubmed publisher |
Luque Martin R, Van den Bossche J, Furze R, Neele A, van der Velden S, Gijbels M, et al. Targeting Histone Deacetylases in Myeloid Cells Inhibits Their Maturation and Inflammatory Function With Limited Effects on Atherosclerosis. Front Pharmacol. 2019;10:1242 pubmed publisher |
Chu L, Yang C, Peng K, Chen P, Wang S, Ping Y. TIM-1 As a Signal Receptor Triggers Dengue Virus-Induced Autophagy. Int J Mol Sci. 2019;20: pubmed publisher |
Galle Treger L, Sankaranarayanan I, Hurrell B, Howard E, Lo R, Maazi H, et al. Costimulation of type-2 innate lymphoid cells by GITR promotes effector function and ameliorates type 2 diabetes. Nat Commun. 2019;10:713 pubmed publisher |
Twomey J, Zhao L, Luo S, Xu Q, Zhang B. Tubulin couples death receptor 5 to regulate apoptosis. Oncotarget. 2018;9:36804-36815 pubmed publisher |
Pizon M, Lux D, Pachmann U, Pachmann K, Schott D. Influence of endocrine therapy on the ratio of androgen receptor (AR) to estrogen receptor (ER) positive circulating epithelial tumor cells (CETCs) in breast cancer. J Transl Med. 2018;16:356 pubmed publisher |
Bozza W, Zhang Y, Zhang B. Cytokeratin 8/18 protects breast cancer cell lines from TRAIL-induced apoptosis. Oncotarget. 2018;9:23264-23273 pubmed publisher |
De Pauw I, Lardon F, Van den Bossche J, Baysal H, Fransen E, Deschoolmeester V, et al. Simultaneous targeting of EGFR, HER2, and HER4 by afatinib overcomes intrinsic and acquired cetuximab resistance in head and neck squamous cell carcinoma cell lines. Mol Oncol. 2018;12:830-854 pubmed publisher |
Brands R, Scheurer M, Hartmann S, Seher A, Kubler A, Müller Richter U. Apoptosis-sensitizing activity of birinapant in head and neck squamous cell carcinoma cell lines. Oncol Lett. 2018;15:4010-4016 pubmed publisher |
Dejosez M, Zwaka T. Generation of hiPSTZ16 (ISMMSi003-A) cell line from normal human foreskin fibroblasts. Stem Cell Res. 2018;26:44-46 pubmed publisher |
Lara Guzmán O, Gil Izquierdo A, Medina S, Osorio E, Álvarez Quintero R, Zuluaga N, et al. Oxidized LDL triggers changes in oxidative stress and inflammatory biomarkers in human macrophages. Redox Biol. 2018;15:1-11 pubmed publisher |
Pan J, Shen J, Si W, Du C, Chen D, Xu L, et al. Resveratrol promotes MICA/B expression and natural killer cell lysis of breast cancer cells by suppressing c-Myc/miR-17 pathway. Oncotarget. 2017;8:65743-65758 pubmed publisher |
Venet F, Demaret J, Blaise B, Rouget C, Girardot T, Idealisoa E, et al. IL-7 Restores T Lymphocyte Immunometabolic Failure in Septic Shock Patients through mTOR Activation. J Immunol. 2017;199:1606-1615 pubmed publisher |
Wu L, Ehlin Henriksson B, Zhou X, Zhu H, Ernberg I, Kis L, et al. Epstein-Barr virus (EBV) provides survival factors to EBV+ diffuse large B-cell lymphoma (DLBCL) lines and modulates cytokine induced specific chemotaxis in EBV+ DLBCL. Immunology. 2017;152:562-573 pubmed publisher |
Singh A, Subhi Y, Krogh Nielsen M, Falk M, Matzen S, Sellebjerg F, et al. Systemic frequencies of T helper 1 and T helper 17 cells in patients with age-related macular degeneration: A case-control study. Sci Rep. 2017;7:605 pubmed publisher |
Fischer M, Müller J, Spies Weisshart B, Grafe C, Kurzai O, Hünniger K, et al. Isoform localization of Dectin-1 regulates the signaling quality of anti-fungal immunity. Eur J Immunol. 2017;47:848-859 pubmed publisher |
Koenen A, Babendreyer A, Schumacher J, Pasqualon T, Schwarz N, Seifert A, et al. The DRF motif of CXCR6 as chemokine receptor adaptation to adhesion. PLoS ONE. 2017;12:e0173486 pubmed publisher |
Ryzhov S, Matafonov A, Galindo C, Zhang Q, Tran T, Lenihan D, et al. ERBB signaling attenuates proinflammatory activation of nonclassical monocytes. Am J Physiol Heart Circ Physiol. 2017;312:H907-H918 pubmed publisher |
Dendrou C, Cortes A, Shipman L, Evans H, Attfield K, Jostins L, et al. Resolving TYK2 locus genotype-to-phenotype differences in autoimmunity. Sci Transl Med. 2016;8:363ra149 pubmed |
Sugita S, Iwasaki Y, Makabe K, Kimura T, Futagami T, Suegami S, et al. Lack of T Cell Response to iPSC-Derived Retinal Pigment Epithelial Cells from HLA Homozygous Donors. Stem Cell Reports. 2016;7:619-634 pubmed publisher |
Fischer M, Spies Weisshart B, Schrenk K, Gruhn B, Wittig S, Glaser A, et al. Polymorphisms of Dectin-1 and TLR2 Predispose to Invasive Fungal Disease in Patients with Acute Myeloid Leukemia. PLoS ONE. 2016;11:e0150632 pubmed publisher |
Zhang N, Deng J, Wu F, Lu X, Huang L, Zhao M. Expression of arginase I and inducible nitric oxide synthase in the peripheral blood and lymph nodes of HIV‑positive patients. Mol Med Rep. 2016;13:731-43 pubmed publisher |
Wang W, Yen M, Liu K, Hsu P, Lin M, Chen P, et al. Interleukin-25 Mediates Transcriptional Control of PD-L1 via STAT3 in Multipotent Human Mesenchymal Stromal Cells (hMSCs) to Suppress Th17 Responses. Stem Cell Reports. 2015;5:392-404 pubmed publisher |
Mir H, Singh R, Kloecker G, Lillard J, Singh S. CXCR6 expression in non-small cell lung carcinoma supports metastatic process via modulating metalloproteinases. Oncotarget. 2015;6:9985-98 pubmed |
Yang Y, Du L, Yang X, Qu A, Zhang X, Zhou C, et al. Aberrant CCR4 expression is involved in tumor invasion of lymph node-negative human gastric cancer. PLoS ONE. 2015;10:e0120059 pubmed publisher |
Warat M, Sadowski T, Szliszka E, Krol W, Czuba Z. The role of selected flavonols in tumor necrosis factor-related apoptosis-inducing ligand receptor-1 (TRAIL-R1) expression on activated RAW 264.7 macrophages. Molecules. 2015;20:900-12 pubmed publisher |
Huang L, Nakayama H, Klagsbrun M, Mulliken J, Bischoff J. Glucose transporter 1-positive endothelial cells in infantile hemangioma exhibit features of facultative stem cells. Stem Cells. 2015;33:133-45 pubmed publisher |
Warat M, Szliszka E, Korzonek Szlacheta I, Krol W, Czuba Z. Chrysin, apigenin and acacetin inhibit tumor necrosis factor-related apoptosis-inducing ligand receptor-1 (TRAIL-R1) on activated RAW264.7 macrophages. Int J Mol Sci. 2014;15:11510-22 pubmed publisher |
Hu W, Liu Y, Zhou W, Si L, Ren L. CXCL16 and CXCR6 are coexpressed in human lung cancer in vivo and mediate the invasion of lung cancer cell lines in vitro. PLoS ONE. 2014;9:e99056 pubmed publisher |
Robinet P, Baychelier F, Fontaine T, Picard C, Debre P, Vieillard V, et al. A polysaccharide virulence factor of a human fungal pathogen induces neutrophil apoptosis via NK cells. J Immunol. 2014;192:5332-42 pubmed publisher |
Gonzalvo Feo S, Del Prete A, Pruenster M, Salvi V, Wang L, Sironi M, et al. Endothelial cell-derived chemerin promotes dendritic cell transmigration. J Immunol. 2014;192:2366-73 pubmed publisher |
Kachroo P, Lee M, Zhang L, Baratelli F, Lee G, Srivastava M, et al. IL-27 inhibits epithelial-mesenchymal transition and angiogenic factor production in a STAT1-dominant pathway in human non-small cell lung cancer. J Exp Clin Cancer Res. 2013;32:97 pubmed publisher |
Di X, Zhang G, Zhang Y, Takeda K, Rivera Rosado L, Zhang B. Accumulation of autophagosomes in breast cancer cells induces TRAIL resistance through downregulation of surface expression of death receptors 4 and 5. Oncotarget. 2013;4:1349-64 pubmed |
Li D, Dong B, Tong Z, Wang Q, Liu W, Wang Y, et al. MBL-mediated opsonophagocytosis of Candida albicans by human neutrophils is coupled with intracellular Dectin-1-triggered ROS production. PLoS ONE. 2012;7:e50589 pubmed publisher |
Redondo S, González Rocafort A, Navarro Dorado J, Ramajo M, Hristov M, Gordillo Moscoso A, et al. Decreased pre-surgical CD34+/CD144+ cell number in patients undergoing coronary artery bypass grafting compared to coronary artery disease-free valvular patients. J Cardiothorac Surg. 2012;7:2 pubmed publisher |
Garimella S, Rocca A, Lipkowitz S. WEE1 inhibition sensitizes basal breast cancer cells to TRAIL-induced apoptosis. Mol Cancer Res. 2012;10:75-85 pubmed publisher |
Noyce R, Bondre D, Ha M, Lin L, Sisson G, Tsao M, et al. Tumor cell marker PVRL4 (nectin 4) is an epithelial cell receptor for measles virus. PLoS Pathog. 2011;7:e1002240 pubmed publisher |
Rauert H, Stühmer T, Bargou R, Wajant H, Siegmund D. TNFR1 and TNFR2 regulate the extrinsic apoptotic pathway in myeloma cells by multiple mechanisms. Cell Death Dis. 2011;2:e194 pubmed publisher |
Szliszka E, Helewski K, Mizgala E, Krol W. The dietary flavonol fisetin enhances the apoptosis-inducing potential of TRAIL in prostate cancer cells. Int J Oncol. 2011;39:771-9 pubmed publisher |
Zhang B, Shan H, Li D, Li Z, Zhu K, Jiang Z, et al. Cisplatin sensitizes human hepatocellular carcinoma cells, but not hepatocytes and mesenchymal stem cells, to TRAIL within a therapeutic window partially depending on the upregulation of DR5. Oncol Rep. 2011;25:461-8 pubmed publisher |
McDermott D, De Ravin S, Jun H, Liu Q, Priel D, Noel P, et al. Severe congenital neutropenia resulting from G6PC3 deficiency with increased neutrophil CXCR4 expression and myelokathexis. Blood. 2010;116:2793-802 pubmed publisher |
Elias A, Siegelin M, Steinmüller A, von Deimling A, Lass U, Korn B, et al. Epigenetic silencing of death receptor 4 mediates tumor necrosis factor-related apoptosis-inducing ligand resistance in gliomas. Clin Cancer Res. 2009;15:5457-65 pubmed publisher |
Ehlin Henriksson B, Liang W, Cagigi A, Mowafi F, Klein G, Nilsson A. Changes in chemokines and chemokine receptor expression on tonsillar B cells upon Epstein-Barr virus infection. Immunology. 2009;127:549-57 pubmed publisher |
Miller C, Lowe K, Valliant Saunders K, Kaiser J, Mattern D, Urban N, et al. Evaluating erythropoietin-associated tumor progression using archival tissues from a phase III clinical trial. Stem Cells. 2009;27:2353-61 pubmed publisher |
Ahern D, Lloyd C, Robinson D. Chemokine responsiveness of CD4+ CD25+ regulatory and CD4+ CD25- T cells from atopic and nonatopic donors. Allergy. 2009;64:1121-9 pubmed publisher |
Dai C, Tiwari A, Wu C, Su X, Wang S, Liu D, et al. Lapatinib (Tykerb, GW572016) reverses multidrug resistance in cancer cells by inhibiting the activity of ATP-binding cassette subfamily B member 1 and G member 2. Cancer Res. 2008;68:7905-14 pubmed publisher |
Zhang Y, Fisher N, Newey S, Smythe J, Tatton L, Tsaknakis G, et al. The impact of proliferative potential of umbilical cord-derived endothelial progenitor cells and hypoxia on vascular tubule formation in vitro. Stem Cells Dev. 2009;18:359-75 pubmed publisher |
